NuVasive Investor Relations

NuVasive is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes.

FAQs

1.What is NuVasive®’s, Inc. ticker symbol and on what exchange does it trade?
2.When was NuVasive’s initial public offering and what was the offering price?
3.Where is NuVasive headquartered?
4.Where is NuVasive incorporated?
5.When does NuVasive’s fiscal year end?
6.Who is NuVasive’s independent auditor?
7.Who is on NuVasive’s Board of Directors?
8.Who is NuVasive’s transfer agent and how does one contact them regarding my stock certificates or change of address?
9.Does NuVasive currently pay a dividend on its common stock?
10.Does NuVasive offer a direct stock purchase plan?
11.Who are the financial analysts that cover NuVasive and what are their expectations for future growth?
12.Does NuVasive issue quarterly reports?
13.What is NuVasive’s CUSIP number?
14.How can I get stock prices for NuVasive?
15.How can I contact someone at NuVasive with a question or request?
16.How can I be placed on the NuVasive’s e-mail news distribution list?
17.How can I obtain additional financial or investor information on NuVasive?
18.How can I obtain the latest quarterly earnings information?
What is NuVasive®’s, Inc. ticker symbol and on what exchange does it trade?
NuVasive®, Inc. trades on the NASDAQ Global Select Market under the ticker symbol “NUVA.”
BACK TO TOP
When was NuVasive’s initial public offering and what was the offering price?
NuVasive’s initial public offering (IPO) was completed on May 13, 2004. After giving effect to the exercise of the over-allotment option, the Company sold a total of 6,882,991 shares in the underwritten offering at $11.00 per share, resulting in total net proceeds of approximately $70.4 million.
BACK TO TOP
Where is NuVasive headquartered?

NuVasive’s principal executive offices are located at:

7475 Lusk Blvd.
San Diego, California 92121
Tel: 858-909-1800
Fax: 858-909-2000
Email: investorrelations@nuvasive.com

BACK TO TOP
Where is NuVasive incorporated?
NuVasive was incorporated in Delaware in 1997, and since that time has focused primarily on research and development, and seeking regulatory clearances to market products. The Company began commercial sales of products in 2001, launched the NeuroVision® Nerve Monitoring System in November 2002 and launched the MaXcess® Access System in November 2003.
BACK TO TOP
When does NuVasive’s fiscal year end?
NuVasive operates on a December 31 fiscal year end.
BACK TO TOP
Who is NuVasive’s independent auditor?
The Company’s independent auditor is Ernst & Young LLP.
BACK TO TOP
Who is on NuVasive’s Board of Directors?
To view a complete Board list with biographies, click on the Board of Directors link in the Investor Relations section of the Company’s Web site.
BACK TO TOP
Who is NuVasive’s transfer agent and how does one contact them regarding my stock certificates or change of address?

The Company’s transfer agent is Computershare Trust Company, N.A.. They can be contacted directly via email at the addresses below for address changes, stock transfers, proxy voting, or any other questions regarding NuVasive stock certificates. The customer service phone number for Computershare Trust Company, N.A.is (800) 962-4284.

For DWAC instructions provided to brokers
FAST Transfer Agent number – 50173

For standard US postal mail
Computershare Trust Company, N.A.
Po Box 43070
Providence, RI 02940-3070

For overnight/express delivery
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021

Telephone and Fax
Toll free +1 800 962 4284
Telephone +1 303-262-0600
Fax +1 303-262-0700

Website
www.computershare.com

BACK TO TOP
Does NuVasive currently pay a dividend on its common stock?
NuVasive does not currently pay a dividend on its common stock.
BACK TO TOP
Does NuVasive offer a direct stock purchase plan?
The Company does not currently offer a direct stock purchase plan.
BACK TO TOP
Who are the financial analysts that cover NuVasive and what are their expectations for future growth?
A complete listing of covering analysts can be found by clicking on the Analyst Coverage link.
BACK TO TOP
Does NuVasive issue quarterly reports?
The Company does complete a quarterly form 10Q with the Securities and Exchange Commission (SEC). To view this form, and other SEC filings of NuVasive, click on the SEC Filings link in the Investor Relations section of the Company Web site.
BACK TO TOP
What is NuVasive’s CUSIP number?
The Company’s CUSIP number is 670704303.
BACK TO TOP
How can I get stock prices for NuVasive?
Historical stock closing prices can be obtained by visiting the Stock Quote link on the Investor Relations section of the Company Web site. There is also the option to sign-up for end-of-day NuVasive stock quote email alerts.
BACK TO TOP
How can I contact someone at NuVasive with a question or request?
Please visit the Information Request page in the Investor Relations section of the Company Web site.
BACK TO TOP
How can I be placed on the NuVasive’s e-mail news distribution list?
To be placed on the Company’s e-mail news distribution list, please visit the Investor Relations section of the Company Web site and type your email address in the “Email Alerts” section on the right hand side of the page.
BACK TO TOP
How can I obtain additional financial or investor information on NuVasive?
Current or potential investors that wish to obtain more information about NuVasive should visit the Information Request link in the Investor Relations section of the Company’s Web site.
BACK TO TOP
How can I obtain the latest quarterly earnings information?
The most recent quarterly earnings information can be obtained from the Press Releases link on the Investor Relations section of the Company Web site.
BACK TO TOP